Prospective genomically guided identification of “early/evolving” and “undersampled” IDH-wildtype glioblastoma leads to improved clinical outcomes

Yalan Zhang(University of California, San Francisco), David A. Solomon(University of California, San Francisco), Jacob S. Young(University of California, San Francisco), Mitchel S. Berger(University of California, San Francisco), Mariza Daras(University of California, San Francisco), Joanna J. Phillips(University of California, San Francisco), John K. Wiencke(Neurological Surgery), Ramin A. Morshed(University of California, San Francisco), Annette M. Molinaro(Yale University), Shawn L. Hervey‐Jumper(University of California, San Francisco), Philip V. Theodosopoulos(University of California, San Francisco), Manish K. Aghi(Neurological Surgery), Andrew W. Bollen(University of California, San Francisco), Javier Villanueva-Meyer(University of California, San Francisco), Jennifer Clarke(Cornell University), Arie Perry(University of California, San Francisco), Lucie McCoy(University of California, San Francisco), Melike Pekmezci(University of California, San Francisco), Margaret Wrensch(University of California, San Francisco), Soonmee Cha(University of California, San Francisco), Jennie Taylor(University of California, San Francisco), Nicholas Butowski(University of California, San Francisco), Edward F. Chang, Nancy Ann Oberheim Bush(University of California, San Francisco), Julieann C. Lee(University of California, San Francisco), Susan M. Chang(University of California, San Francisco), Calixto‐Hope G. Lucas(Johns Hopkins University)
Neuro-Oncology
April 8, 2022
Cited by 31


Related Papers